G5 Neocusser By General Physiotherapy
The Benefits of the G5 Neiocusser
G5 Neocusser by General Physiotherapy
The G5 Neocussor is a unique product in the market, specifically designed to improve the lung function of neonates. Its compact design is intended for use in neonatal chambers, making it a vital tool for healthcare professionals working with premature babies and infants. The Neocussor utilizes G5’s unique gyratory percussion technology, providing both multi-directional and directional stroking patterns. This allows the device to more accurately mimic advanced hand techniques compared to the straight percussors offered by competitors like Theragun and Hyperice.
Incredibly easy to use, the Neocussor is designed to be sent home with parents after discharge, enabling them to continue providing essential care for their newborns. Studies have shown that the Neocussor can improve neonate outcomes, reduce hospital recidivism rates, and loosen secretions and buildup in neonates, reducing the risk of sepsis.
As a core product in the neonatal therapy market, the G5 Neocussor is FDA cleared, ensuring its safety and effectiveness in providing the best possible care to newborns. Its easy-to-use design makes it an essential tool for nurses and parents alike, helping to stimulate the lungs of premature babies, reduce the risk of sepsis, and ultimately save lives.
G5 Neocusser by General Physiotherapy
The G5 Neocussor is a unique product in the market, specifically designed to improve the lung function of neonates. Its compact design is intended for use in neonatal chambers, making it a vital tool for healthcare professionals working with premature babies and infants. The Neocussor utilizes G5’s unique gyratory percussion technology, providing both multi-directional and directional stroking patterns. This allows the device to more accurately mimic advanced hand techniques compared to the straight percussors offered by competitors like Theragun and Hyperice.
Incredibly easy to use, the Neocussor is designed to be sent home with parents after discharge, enabling them to continue providing essential care for their newborns. Studies have shown that the Neocussor can improve neonate outcomes, reduce hospital recidivism rates, and loosen secretions and buildup in neonates, reducing the risk of sepsis.
As a core product in the neonatal therapy market, the G5 Neocussor is FDA cleared, ensuring its safety and effectiveness in providing the best possible care to newborns. Its easy-to-use design makes it an essential tool for nurses and parents alike, helping to stimulate the lungs of premature babies, reduce the risk of sepsis, and ultimately save lives.
